Benign Prostatic Hyperplasia (BPH)

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

BPH Surgery Complication Rates Underestimated

Jody A. Charnow April 30, 2012

PARIS—Complication rates after surgery for benign prostatic hyperplasia (BPH) are higher in real clinical practice than in clinical trials.

Open Prostatectomy, TURP Are the Most Common BPH Surgeries

Jody A. Charnow April 25, 2012

Despite the emergence of new surgical techniques to treat benign prostatic hyperplasia (BPH), open prostatectomy (OP) and monopolar transurethral resection of the prostate (TURP) remain the procedures used most by urologists, according to a recent survey.

Prostatic Artery Embolization Eases BPH Symptoms

John Schieszer March 27, 2012

SAN FRANCISCO—Benign prostatic hyperplasia (BPH) may be safely treated with prostatic artery embolization (PAE), according to a new study presented at the 37th Annual Scientific Meeting of the Society of Interventional Radiology (SIR).

NSAIDs Do Not Protect Against BPH/LUTS

Jody A. Charnow March 21, 2012

Recent use of nonsteroidal anti-inflammatory agents (NSAIDs) do not protect against development of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), a new study concluded.

Finasteride Prevents BPH, Study Finds

Jody A. Charnow March 14, 2012

Finasteride use decreases the risk of clinical benign prostatic hyperplasia (BPH), according to researchers.

Severe Post-Transplant LUTS May Be Predictable

Jody A. Charnow March 02, 2012

QUEBEC CITY—Evaluation of lower urinary tract symptoms (LUTS) using validated questionnaires prior to renal transplantation (Tx) may predict which patients will experience significant LUTS after transplantation, researchers reported at the Canadian Society of Transplantation annual meeting.

PDE-5 Inhibitors Improve LUTS in Men

Jody A. Charnow February 26, 2012

PARIS—Phosphodiesterase-5 (PDE-5) inhibitors significantly improve lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and can be considered as an alternative treatment for BPH-related LUTS in men with or without erectile dysfunction, researchers reported at the 27th Annual Congress of the European Association of Urology.

Metabolic Syndrome Raises BPH Risk

Jody A. Charnow February 25, 2012

PARIS—Metabolic syndrome increases a man's risk of developing benign prostatic hyperplasia (BPH) and the risk of prostatic inflammation in men who have BPH, according to reports at the 27th Annual Congress of the European Association of Urology.

Prostatic Urethral Lift Relieves Lower Urinary Tract Symptoms

January 03, 2012

Use of a prostatic urethral lift procedure, a minimally invasive treatment for lower urinary tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH), preserves sexual function, according to a study published online ahead of print in The Journal of Sexual Medicine.

Study: Electromagnetic Treatment Improves BPH

Jody A. Charnow December 19, 2011

Radiofrequency pulsed electromagnetic fields (EMF) may provide a non-invasive treatment for benign prostatic hyperplasia (BPH), researchers reported.

Epinephrine Can Cut TURP-Related Blood Loss

Jody A. Charnow December 13, 2011

Epinephrine injected into the prostate can be used to decrease blood loss during transurethral resection of the prostate (TURP), according to researchers.

HoLEP's Benefits As BPH Treatment Durable Out to 10 Years

Stephan Cho October 31, 2011

Holmium laser enucleation of the prostate (HoLEP) is an effective treatment for benign prostatic hyperplasia (BPH) that has long-term durable clinical outcomes, researchers concluded.

Saw Palmetto No More Effective than Placebo for BPH

Delicia Honen Yard October 14, 2011

Saw palmetto fruit extracts are widely used to treat lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH), but a new study shows that these extracts are no better than placebo at easing symptoms, according to investigators.

Erectile Dysfunction Drug Approved as BPH Treatment

Jody A. Charnow October 08, 2011

The FDA has approved tadalafil (Cialis) for the once daily use as a treatment for benign prostatic hyperplasia (BPH). The agency also approved the medication for once daily use as a treatment for men with both erectile dysfunction (ED) and BPH.

PCa More Likely in BPH Sufferers

Jody A. Charnow October 01, 2011

Prostate cancer (PCa) is more likely to be diagnosed in men who have been hospitalized for clinical benign prostatic hyperplasia (BPH) or undergone surgery for the condition, according to a Danish study.

Higher CRP Levels Predict Residual Urgency in BPH Patients

Jody A. Charnow August 31, 2011

GLASGOW—Serum C-reactive protein (CRP) levels, a marker of systemic inflammation, are associated with residual urgency after medical treatment for benign prostatic hyperplasia (BPH), according to new findings presented at the International Continence Society annual meeting.

Botulinum Toxin Injections Effective for BPH

Jody A. Charnow August 30, 2011

GLASGOW—Intraprostatic injections of botulinum neurotoxin type A (BoNT-A) are a safe and effective treatment for benign prostatic hyperplasia (BPH), according to a study presented at the International Continence Society annual meeting.

Heavier Men Face Higher LUTS Risk

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Elderly men who are overweight or obese are at increased risk for developing lower urinary tract symptoms (LUTS), but those who engage in a relatively high level of physical activity or daily walking for exercise have a reduced risk, data show.

Severe Adverse BPH Outcomes Persist

Jody A. Charnow May 18, 2011

WASHINGTON, D.C.—Severe adverse outcomes of benign prostatic hyperplasia (BPH) persist despite widespread use of oral therapies, according to a study presented at the American Urological Association 2011 annual meeting.

Overweight Young Men Face High Risk of Enlarged Prostates

Jody A. Charnow May 17, 2011

WASHINGTON, D.C.—Overweight young men are more likely than normal-weight men to develop an enlarged prostate later in life, researchers reported.

Your Practice

The move from ICD-9-CM to ICD-10 is enough to strike fear into the hearts of physicians and staff alike. Making the leap from 14,000 codes to almost 69,000, topped with the huge cost to make that change, is understandably daunting.

Read more on
Coping with ICD-10

Have any practice management topics that you'd like us to cover?
Let us know.

Legal Issues

After Radical Prostatectomy, Patient Learns He Never Had Prostate Cancer

Is honesty always the best policy? That is the question that a urologist had to grapple with in this case.

Commentary

Prostate Cancer Screening: Moving Beyond PSA

The merits of PSA screening have been widely debated due largely to its low specificity for prostate cancer (PCa), especially for high-grade disease.

Expert Q&A

Optimal Sequencing of the New Prostate Cancer Drugs: An Interview with E. David Crawford, MD

Several new drugs have become available for treating advanced prostate cancer in the past year and a half. Dr. Crawford talks to Renal & Urology News about the possible ways in which these drugs might be used.

Cartoons

Click here for our latest cartoons

Clinical Quiz

Small Renal Masses and Drug-Eluting Stents — How to Best Balance the Risks?

A 55-year-old male with significant history of coronary artery disease is found to have an intraparenchymal 2 cm left-enhancing small renal mass. Answer the quiz correctly and you'll have a chance to win an American Express gift card.